WuXi AppTec Becomes Top Short Target as 80% Rally Draws Skeptics

WuXi AppTec Co.'s stock rose 80 percent in 2026, drawing increased short-seller attention to the Chinese biotech firm. Short sellers typically bet that a stock's price will decline. The company provides drug discovery and development services to pharmaceutical and biotechnology clients globally.

Next story